InvestorsHub Logo
Followers 134
Posts 3737
Boards Moderated 0
Alias Born 01/28/2006

Re: Basil22 post# 402354

Wednesday, 04/17/2024 11:55:12 AM

Wednesday, April 17, 2024 11:55:12 AM

Post# of 402685
It was Kevetrin not Brilacidin. It is a shame Kevetrin never made the cut for a clinical trial for retinoblastoma.

https://www.fdanews.com/articles/174349-cellceutixs-kevetrin-wins-rare-pediatric-disease-designation

Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News